ARCA biopharma (ABIO) Stock Highlights

28.8 | -4%

2024-09-19 06:46:29

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The companys product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.

Statistics

Range Today

26.64 29.64

Volume Today 24.24K

Range 1 Year

1.56 52.32

Volume 1 Year 98.7M

Range 3 Year

1.56 52.32

Volume 3 Year 154.14M

Range 10 Year

1.56 195.3

Volume 10 Year 527.35M

Highlights

Market Capitalization 34.82M (micro)

Floating Shares 4.79M

Current Price 28.8

Price To Earnings -0.4

Price To Book 12.83

Earnings Per Share -5.88

Payout Ratio 0%

Performance

Latest -4%

1 Month -22.33%

3 Months +734.78%

6 Months +1634.94%

1 Year +1325.74%

3 Years +832.04%

5 Years +416.13%

10 Years -83.67%

Benchmarks

Market Capitalization

320 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

138 / 368

Free Cashflow

64 / 352

Performance 5 years

16 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.